Shugaku Takeda

2.7k total citations
33 papers, 1.5k citations indexed

About

Shugaku Takeda is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shugaku Takeda has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shugaku Takeda's work include Acute Myeloid Leukemia Research (5 papers), Renal cell carcinoma treatment (5 papers) and Cancer Genomics and Diagnostics (5 papers). Shugaku Takeda is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Renal cell carcinoma treatment (5 papers) and Cancer Genomics and Diagnostics (5 papers). Shugaku Takeda collaborates with scholars based in United States, Japan and Norway. Shugaku Takeda's co-authors include James J. Hsieh, Emily H. Cheng, Han Liu, Martin H. Voss, Ying‐Bei Chen, Robert J. Motzer, A. Ari Hakimi, Victor E. Reuter, Paul Russo and Todd D. Westergard and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Shugaku Takeda

32 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shugaku Takeda United States 16 1.2k 535 451 254 112 33 1.5k
Susan Korenchuk United States 13 896 0.8× 462 0.9× 204 0.5× 348 1.4× 76 0.7× 18 1.4k
Ion Cristóbal Spain 22 1.1k 0.9× 177 0.3× 489 1.1× 430 1.7× 75 0.7× 58 1.5k
Harold Hatch United States 7 1.1k 0.9× 277 0.5× 165 0.4× 346 1.4× 121 1.1× 7 1.4k
Mengqian Chen United States 21 691 0.6× 284 0.5× 177 0.4× 347 1.4× 94 0.8× 46 1.1k
Celina M. D’Cruz United States 16 1.1k 0.9× 493 0.9× 299 0.7× 688 2.7× 83 0.7× 38 1.8k
Matteo Dugo Italy 27 1.3k 1.1× 276 0.5× 967 2.1× 430 1.7× 63 0.6× 84 2.0k
Sunita Shankar United States 11 1.6k 1.3× 268 0.5× 873 1.9× 317 1.2× 57 0.5× 21 2.0k
Yukinori Minoshima Japan 17 1.2k 1.0× 213 0.4× 272 0.6× 504 2.0× 331 3.0× 35 1.9k
Reika Iwakawa Japan 19 808 0.7× 525 1.0× 394 0.9× 675 2.7× 59 0.5× 22 1.4k
Timothy P. Heffernan United States 18 837 0.7× 137 0.3× 378 0.8× 476 1.9× 126 1.1× 38 1.3k

Countries citing papers authored by Shugaku Takeda

Since Specialization
Citations

This map shows the geographic impact of Shugaku Takeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shugaku Takeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shugaku Takeda more than expected).

Fields of papers citing papers by Shugaku Takeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shugaku Takeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shugaku Takeda. The network helps show where Shugaku Takeda may publish in the future.

Co-authorship network of co-authors of Shugaku Takeda

This figure shows the co-authorship network connecting the top 25 collaborators of Shugaku Takeda. A scholar is included among the top collaborators of Shugaku Takeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shugaku Takeda. Shugaku Takeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Takeda, Shugaku, Celia Andreu-Agulló, Nils Halberg, et al.. (2019). Abstract LB-277: Characterization of the anti-cancer and immunologic activity of RGX-019, a novel pre-clinical stage humanized monoclonal antibody targeting the MERTK receptor. Cancer Research. 79(13_Supplement). LB–277. 4 indexed citations
3.
Wang, Gary X., Ho-Chou Tu, Yiyu Dong, et al.. (2017). ΔNp63 Inhibits Oxidative Stress-Induced Cell Death, Including Ferroptosis, and Cooperates with the BCL-2 Family to Promote Clonogenic Survival. Cell Reports. 21(10). 2926–2939. 61 indexed citations
4.
Takeda, Shugaku, Satoru Sasagawa, Toshinao Oyama, et al.. (2015). Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription. Journal of Clinical Investigation. 125(3). 1203–1214. 21 indexed citations
5.
Chen, Hui‐Chen, Masayuki Kanai, Akane Inoue‐Yamauchi, et al.. (2015). An interconnected hierarchical model of cell death regulation by the BCL-2 family. Nature Cell Biology. 17(10). 1270–1281. 205 indexed citations
6.
Voss, Martin H., A. Ari Hakimi, Can G. Pham, et al.. (2014). Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy. Clinical Cancer Research. 20(7). 1955–1964. 156 indexed citations
7.
Bean, Gregory R., Yogesh Tengarai Ganesan, Yiyu Dong, et al.. (2013). PUMA and BIM Are Required for Oncogene Inactivation–Induced Apoptosis. Science Signaling. 6(268). ra20–ra20. 97 indexed citations
8.
Hakimi, A. Ari, Irina Ostrovnaya, Boris Reva, et al.. (2013). Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2 : A Report by MSKCC and the KIRC TCGA Research Network. Clinical Cancer Research. 19(12). 3259–3267. 267 indexed citations
9.
Takeda, Shugaku, Han Liu, Satoru Sasagawa, et al.. (2013). HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma. Journal of Clinical Investigation. 123(7). 3154–3165. 51 indexed citations
10.
Oyama, Toshinao, Satoru Sasagawa, Shugaku Takeda, et al.. (2013). Cleavage of TFIIA by Taspase1 Activates TRF2-Specified Mammalian Male Germ Cell Programs. Developmental Cell. 27(2). 188–200. 29 indexed citations
11.
Hakimi, A. Ari, Ying‐Bei Chen, James Wren, et al.. (2012). Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell Carcinoma. European Urology. 63(5). 848–854. 174 indexed citations
12.
Chen, David Y., Shugaku Takeda, Toshinao Oyama, & James J. Hsieh. (2012). Targeting Taspase1 for Cancer Therapy—Response. Cancer Research. 72(11). 2913–2913. 3 indexed citations
13.
Voss, Martin H., A. Ari Hakimi, Sasinya N. Scott, et al.. (2012). Genetic determinants of long-term response to rapalog therapy in advanced renal cell carcinoma (RCC).. Journal of Clinical Oncology. 30(15_suppl). 4604–4604. 3 indexed citations
14.
Chen, David Y., Brian A. Van Tine, Adam C. Searleman, et al.. (2011). A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth. Cancer Research. 72(3). 736–746. 35 indexed citations
15.
Chen, David Y., Han Liu, Shugaku Takeda, et al.. (2010). Taspase1 Functions as a Non-Oncogene Addiction Protease that Coordinates Cancer Cell Proliferation and Apoptosis. Cancer Research. 70(13). 5358–5367. 29 indexed citations
16.
Liu, Han, Shugaku Takeda, Rakesh Kumar, et al.. (2010). Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint. Nature. 467(7313). 343–346. 113 indexed citations
17.
Miles, Wayne, Ellis Jaffray, Susan G. Campbell, et al.. (2008). Medea SUMOylation restricts the signaling range of the Dpp morphogen in the Drosophila embryo. Genes & Development. 22(18). 2578–2590. 40 indexed citations
18.
Liu, Han, Shugaku Takeda, Emily H. Cheng, & James J. Hsieh. (2008). Biphasic MLL takes helm at cell cycle control: Implications in human mixed lineage leukemia. Cell Cycle. 7(4). 428–435. 27 indexed citations
19.
Muramoto, Tetsuya, Shugaku Takeda, Yoko Furuya, & Hideko Urushihara. (2005). Reverse genetic analyses of gamete-enriched genes revealed a novel regulator of the cAMP signaling pathway in Dictyostelium discoideum. Mechanisms of Development. 122(5). 733–743. 15 indexed citations
20.
Takeda, Shugaku, et al.. (1988). [The significance of measuring inhibition of thymidylate synthase activity as a parameter for antitumor activity of 5-fluorouracil derivatives].. PubMed. 15(7). 2125–30. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Korenchuk Breakdown of academic impact, for papers by Ion Cristóbal Breakdown of academic impact, for papers by Harold Hatch Breakdown of academic impact, for papers by Mengqian Chen Breakdown of academic impact, for papers by Celina M. D’Cruz Breakdown of academic impact, for papers by Matteo Dugo Breakdown of academic impact, for papers by Sunita Shankar Breakdown of academic impact, for papers by Yukinori Minoshima Breakdown of academic impact, for papers by Reika Iwakawa Breakdown of academic impact, for papers by Timothy P. Heffernan
Rankless by CCL
2026